首页> 外文会议>International Symposium on Current Progress in Mathematics and Sciences >Solubilization of gliclazide in microemulsion stabilized using saponin-based surfactants from leaf extract of Orthosiphonaristatus (Blume) Miq
【24h】

Solubilization of gliclazide in microemulsion stabilized using saponin-based surfactants from leaf extract of Orthosiphonaristatus (Blume) Miq

机译:使用基于Saponin的表面活性剂溶解在微乳液中的微乳液,从脱螺螺母(Blume)MIQ的叶提取物中皂苷表面活性剂稳定

获取原文

摘要

Gliclazide is an antidiabetic drug that has a low solubility in water, so it has low bioavailability. To improve the gliclazide solubility in water, oil in water (o/w) microemulsion system is used. In this study, solubilization of gliclazide in microemulsion that emulsified using saponin-based surfactants from leaf extract of Orthosiphonaristatus (Blume) Miq has been investigated. The oil phase used is palm oil. The preparation of microemulsion was conducted by titration method with various ratios of surfactant and co-surfactant, and ratios of oil with surfactant and co-surfactant mixture. The stability of microemulsion was observed using turbidimeter, microscope, and particle size analyzer (PSA). Solubilization of gliclazide was observed by UV-Vis spectrophotometer and FTIR spectroscopy. The optimum condition of microemulsion formation was resulted in the ratio of surfactant to co-surfactant (Sm) at 8:2, and ratio of surfactant and co-surfactant mixture (Sm) to oil at 10:1. Size distribution of microemulsion particle was confirmed as 10.92 nm, and microemulsion size after gliclazide addition as 91.21 nm using PSA. The optimum result of gliclazide solubility in o/w microemulsion was obtained at 1.6 mg/mL.
机译:Gliclazide是一种抗糖尿病药物,在水中具有低溶解度,因此具有较低的生物利用度。为了改善水中的Gliclazide溶解度,使用水中的油(O / W)微乳液系统。在该研究中,研究了从脱螺螺母(BLUME)MIQ的叶提取物中乳化的微乳液中的Gliclazide在微乳液中的溶解。使用的油相是棕榈油。通过具有各种表面活性剂和共表面活性剂的滴定方法进行微乳液的制备,以及用表面活性剂和共表面活性剂混合物的油的比例。使用浊度计,显微镜和粒度分析仪(PSA)观察微乳液的稳定性。通过UV-Vis分光光度计和FTIR光谱观察到Gliclazide的溶解。微乳液形成的最佳条件导致表面活性剂与辅助表面活性剂(SM)的比率在8:2中,以及表面活性剂和共表面活性剂混合物(SM)与10:1的副表面活性剂(Sm)的比率。微乳液颗粒的尺寸分布被证实为10.92nm,并且在Gliclazide之后的微乳液尺寸加入为91.21nm,使用PSA。在1.6mg / ml下获得O / W微乳液中的Gliclazide溶解度的最佳结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号